I do not know how many reactions occur with the presently available pertussis vaccines but, other things being equal, with the recent increase in the antigenic content of the vaccine one might predict more frequent reactions. As I have pre-15 371
I am not entirely convinced that the community benefit of whooping-cough vaccination outweighs the damage which it may be doing. Until we began working with quadruple vaccine I was under the impression that, although whoopingcough vaccination was often followed by fever and some irritability, it rarely caused severe reactions (Table 1) . In addition to persistent screaming and collapse, which are presumably of central rather than peripheral origin, serious brain damage occasionally follows whooping-coughvaccination. The onset of these encephalopathies usually occurs within twenty-four hours of inoculation and half of them within six hours; about onethird of the patients die, one-third appear to recover and one-third have residual and often severe brain damage. I knew of 2 such cases while working in Belfast and I estimated that the rate was about 1:10 000 immunized children.
There are few such reports from the rest of the United Kingdom. If the rates which I have calculated for Belfast, the Midlands and Portsmouth in the 1960s (Dick 1971) are applicable for the rest of the country, there could have been 80 such cases per year. There is, in general, a considerable underreporting of all reactions following immunization by physicians. Severe brain damage is so rare that most doctors will not have seen such a complication and may not associate it with the vaccine. Also, one is unlikely to associate a complication with a procedure which one has recommended and may have persuaded a mother to accept for her baby. From the available data, it looks as if the incidence of brain damage following vaccination for whooping-cough in the United Kingdom in the 1960s could be of the order of 1-2 in 10000 vaccinees. More information is required to make an accurate estimate. In Sweden, Str6m (1970) reported neurological reactions in 1 in 3000-4000 children. So concerned were the authorities in Denmark with the reactions to the pertussis component that they no longer recommend the use of triple vaccine routinely but give diphtheria and tetanus toxoid together and whooping-cough vaccine by itself for those who wish to have it. In Holland, it is now admitted that 'all known major reactions after pertussis do occur with Dutch DPT vaccine' (Hannik 1970 (Dick 1971) , the fall in the mortality from scarlet fever and streptococcal sore throats, for which, of course, no routine vaccines have been used, parallels that from whooping-cough and I doubt if whooping-cough vaccine has made any appreciable difference to the death rates from whooping-cough.
When Sydenham described febris scarlatina in 1675, he regarded it as a mild and rarely fatal disease: from the middle to the end of the next century it was a killer but it again became mild at the beginning of the nineteenth century although it remained common. Whooping-cough is now a mild disease but this could be unrelated to the use of vaccines. When the vaccine was first introduced, it was said to be about 80% effective and there was a fall in the number of notifications; subsequently notifications have remained at about one-tenth of the pre-immunization level. The fact that in the mid-1960s the efficacy of much British pertussis vaccine was only about 20-250% (Public Health Laboratory Service 1969) made no difference to the fall in mortality or to the trend in notifications. In the late 1960s, the antigenicity of the vaccine is said to have improved (Perkins 1969) but this seems to have had little or no effect on notifications until last year.
About six years ago, I persuaded a number of Medical Officers of Health to take part in a simple study to test the efficacy of the vaccine in the field on the premise that the vaccine seemed to be doing considerable damage and to be only about 200% effective. We decided that a simple and ethically acceptable study would be to use triple vaccine or diphtheria/tetanus with a nonantigenic pertussis component in several different areas and to compare the notifications of pertussis over several years. The problems of diagnosis of 'what is pertussis' were appreciated but it was considered that an answer on the value of the pertussis component on preventing what has been notified for years as pertussis could be obtained.
However, as the vaccine had been improved, we were dissuaded from getting this trial under way Several cases of convulsions and encephalopathy following pertussis vaccination have been reported during the last forty years. Some of the most influential reports, however, have contained minimal information, such as 'twelve cases of permanent brain damage' by a practitioner who completed Toomey's questionnaire of 1949 and 18 cases of 'irreversible brain damage' mentioned to Dick by unnamed doctors (Dick 1972) . Nevertheless, serious consideration should be given to the extent pertussis vaccination contributes to the incidence of convulsions and encephalopathy in early childhood.
Vaccination ofChildren with a History of Convulsions Livingston (1972) administered pertussis vaccine to 96 children with a history of febrile convulsions. Ten of the children had a convulsion following vaccination. A booster dose of vaccine produced no significant effect in 298 children who had idiopathic epilepsy and only temporarily increased the number of fits in some of 284 children who had secondary epilepsy. Observations on another 13 000 similar children between 1954-1972 appear to confirm his conclusion that a history of convulsions need not be regarded as a contraindication to vaccination. Brody & Sorley (1947), however, found that each of three spaced injections of pertussis vaccine given to a child who had recovered after encephalitis precipitated a relapse, the last proving fatal. In Britain, a uniovular twin who had a prevaccination history ofconvulsions and transient hemiplegia developed convulsions leading to permanent brain damage after pertussis vaccination (Anderson & Morris 1950). Her normal healthy sister was unaffected by the vaccine. These cases indicate that it is inadvisable to administer pertussis vaccine to children with a history of brain damage or convulsions, especially as whooping-cough is no longer a prevalent infection in young children.
Background Incidence ofConvulsions
Between 5-7 % of children have at least one convulsion before they are 7 (Ounstead 1971). The first and often the only convulsion commonly occurs when the child is between 6 and 24 months of age. The incidence of first convulsions in infants of that age group is around 1.2 %/annum or 3/100 000 children/day. Since two million doses of diphtheria-tetanus-pertussis (DTP) vac-
